TTRX vs VTRS · $187.1M cap vs rev $7.27B
Turn Therapeutics Inc. Common Stock (TTRX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
TTRX does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
TTRX currently screens at market cap $187.1M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the TTRX and VTRS stock pages for the full models.
Not investment advice.